MARDİN'DE 60 YAŞ ÜZERİNDEKİLERDE AŞI KARŞILIĞI - AŞI ORANINDA DÜŞÜK BİR BÖLGE/TÜRKİYE

Year 2022, Volume: 12 Issue: 1, 81 - 85, 15.01.2022

Alev Başaran Barış Çil

https://doi.org/10.16899/jcm.1024259

Cited By: 1

Abstract

Amaç: Bulaşıcı hastalıkların önlenmesinde en önemli halk sağlığı uygulamalarından biri aşılamadır. Bu çalışmada COVID-19’ a karşı aşılanmadın düşük olduğu şehirlerde 60 yaş üstü bireylerde aşı tutumu değerlendirilmek istendi.
Material ve Method: Araştırmamız Mardin/Türkiye ilinde 60 yaş üstü 396 kişiye ulaşılarak yapıldı. Katılımcılara aşıya karşı olumlu ve olumsuz tutumlarını içeren bir anket yüzyüze sorularak dolduruldu.
bulgular: Çalışmanın yapıldığı illerde aşı yaptırmayan katılımcıların 110 (%45,8)’ unun aşıya güvenmediğini gördük. Yine aşı yaptırmayanların 128 (%53,3) ‘inin okur yazar olmadığı, 68(%28,3) ‘ininse ilkokul mezunu olduğu görüldü. Aşı yaptırmayan grupta üniversite mezunu yoktu. Olumlu ve olumsuz tutumlar değerlendirildiğinde ilk fırsatta aşı olmak isterim olumlu tutumuna 64 (%16,2) kişinin kesinlikle katılmıyorum, bence herkes aşı olmalı olumlu tutumuna 48(%12,1) kişinin kesinlikle katılmıyorum cevabını verdiği görüldü. Aşı hakkında yapılan çalışmalara güveniyorum olumlu tutumu incelendiğinde 108(%27,3) kişinin kesinlikle katılmıyorum cevabını verdiği görüldü. Yine Aşı yaptırmayan katılımcıların %53,3’ünün okur-yazar olmadığını, %28,3’ünün ilkokul mezunu olduğu görüldü.
sonuç: Aşı güvenliği konusundaki yüksek düzeyde endişenin giderilmesi gerekmektedir. Aşının gelecekteki tanıtımı bu endişeleri gidermeli ve düzgün ve kapsamlı bir şekilde test edilmiş bir aşı, halkın güvenini kazanmaya yardımcı olacaktır. Ek olarak eğitim seviyesi düştükçe aşı treddütünün artması nedeniyle düşük eğitim seviyeli kitleleri hedef alacak kampanyalar düzenlenmeli, bilgilendirilmeleri sağlanmalıdır.

Keywords

COVID-19 aşısı, aşılanma düşüklüğü, aşı tereddütü

Supporting Institution

YOK

VACCINE OPPOSAL IN PEOPLE OVER 60 YEARS OF AGE IN MARDIN/TURKEY – A TERRITORY WITH LOW RATE OF VACCINATION

Abstract

Objective: One of the most important public health practices in the prevention of communicable diseases is vaccination. In this study, it was desired to evaluate the vaccination attitude of individuals over the age of 60 years in cities where the rate of vaccination against COVID-19 was low rate.

Material and Methods: Our research was carried out by reaching 396 people over the age of 60 in MardinTurkey. A questionnaire including the positive and negative attitudes of the participants towards the vaccine was filled in by face to face interviews.

Results: We found that 110 (45.8%) of the participants who have not been innoculated in the provinces where the study was conducted did not trust the vaccine. Again, it was seen that 128 (53.3%) of those who did not get inoculated were illiterate and 68 (28.3%) were primary school graduates. There were no university graduates in the group that did not receive the vaccine. When positive and negative attitudes were evaluated, it was seen that 64 (16.2%) people strongly disagree with the positive attitude, I would like to be vaccinated at the first opportunity, and 48 (12.1%) strongly disagree with the positive attitude, I think everyone should be vaccinated. When the positive attitude of I trust the studies about the vaccine was examined, it was seen that 108 (27.3%) people gave the answer of strongly disagree. Again, it was seen that 53.3% of the participants who did not get vaccinated were illiterate and 28.3% were primary school graduates.

Conclusion: The high level of concern about vaccine safety needs to be addressed. Future introduction of the vaccine should address these concerns, and a properly and thoroughly tested vaccine will help win the public's trust. In addition, campaigns should be organized to target low-educational groups, and they should be informed, due to the increase in the fear of vaccination as the level of education decreases.

Keywords

COVID-19 vaccine, low vaccination, vaccine hesitancy

References

• 1. M Kabak, B Çil, I Hocanlı. Relationship between leukocyte, neutrophil, lymphocyte, platelet counts, and neutrophil to lymphocyte ratio and polymerase chain reaction positivity. Int Immunopharmacol. 2021 Apr;93:107390.
• 2. B Çil, M Kabak.THE POSSIBLE FACTORS THAT AFFECT THE CLINICAL SEVERITY AND MORTALITY OF COVID PNEUMONIA. Acta Medica Mediterranea, 2020, 36: 3655.
• 3. Qiang Gao, Linlin Bao, Haiyan Mao, Lin Wang et al. Development of an inactivated vaccine candidate for SARS-CoV-2. Science 2020, 369, 77–81.
• 4. Rafael Prieto Curiel, Humberto González Ramírez. Vaccination Strategies Against Covıd 19 And The Difusion Of Anti Vaccination Views. Sci Rep. 2021; 11: 6626.
• 5. Neha Puri, Eric A Coomes, Hourmazd Haghbayan, Keith Gunaratne. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Human Vaccines & Immunotherapeutics, 16:11, 2586-2593.
• 6. Geniş, Bahadır & Gürhan, Nermin & Koç, Medine & Geniş, Çiğdem & Şirin, Burak & Çırakoğlu, Okan & Coşar, Behcet. (2020). Development of Perception and Attitude Scales Associated with the COVID-19 Pandemic. 7. Brit Trogen, David Oshinsky, Arthur Caplan. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust. JAMA 2020, 323, 2460–2461.
• 8. Jarrett, C.; Wilson, R.; O’Leary, M.; Eckersberger, E.; Larson, H.J.; the SAGE Working Group on Vaccine Hesitancy. Strategies for addressing vaccine hesitancy—A systematic review. Vaccine 2015, 33, 4180–4190.
• 9. Sadaf, A.; Richards, J.L.; Glanz, J.; Salmon, D.A.; Omer, S.B. A systematic review of interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine 2013, 31, 4293–4304.
• 10. Larson, H.J.; Jarrett, C.; Eckersberger, E.; Smith, D.M.; Paterson, P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: A systematic review of published literature, 2007–2012. Vaccine 2014, 32, 2150–2159.
• 11. Puri N, Coomes E.A, Haghbayan H, Gunaratne K. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases. Human Vaccines & Immunotherapeutics, 16:11, 2586-2593, DOI: 10.1080/21645515.2020.1780846.
• 12. Jiahao Wang, Rize Jing, Xiaozhen Lai et al. Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China. Vaccines (Basel). 2020 Aug 27;8(3):482.
• 13. Frank, K.; Arim, R. Canadians’ Willingness to Get a COVID-19 Vaccine: Group Differences and Reasons for Vaccine Hesitancy 2020. Available online: https://www150.statcan.gc.ca/n1/pub/45-28-0001/2020001/article/00073-eng.htm(accessed on 12 November 2020).
• 14. Sallam, M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines (Basel). 2021 Feb; 9(2): 160.
• 15. Francesco Di Gennaro, Rita Murri, Francesco Vladimiro Segala et al., Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy. Viruses . 2021 Feb 26;13(3):371 .
• 16. Karadeniz Teknik Üniversitesi - Stratejik Araştırma MerkeziProtokol Dergisi |Yıl 2 | Sayı 1 www.ktu.edu.tr/sam 2021.
• 17. Paulina Pisaniak, Aleksander Tarczon, Milena Konarskaet al.,Parents' Opinions and Knowledge About Vaccination in Poland - A Cross-Sectional Observational StudyInt J Gen Med. 2021; 14: 3235–3242.
• 18. Chiara Cadeddu, Signe Daugbjerg, Walter Ricciardi et al., Beliefs towards vaccination and trust in the scientific community in Italy. Vaccine. 2020 Sep 29;38(42):6609-6617.